Wednesday, 12 Nov 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Alive Raises 6 Crore to Power India’s Experience Economy; Records 90x Growth in Under a Year, Eyes 100 Crore ARR
    Alive Raises 6 Crore to Power India’s Experience Economy; Records 90x Growth in Under a Year, Eyes 100 Crore ARR
    12/11/2025
    Dahua Technology Unveils Next-gen Smart City Solutions powered by Xinghan Large-scale AI Models at SCEWC 2025
    Dahua Technology Unveils Next-gen Smart City Solutions powered by Xinghan Large-scale AI Models at SCEWC 2025
    12/11/2025
    SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
    SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
    11/11/2025
    Global Report Surveying 40,000 People Finds Live Music Is the World’s Favorite Form of Entertainment
    Global Report Surveying 40,000 People Finds Live Music Is the World’s Favorite Form of Entertainment
    11/11/2025
    Sapphire Sport Becomes 359 Capital
    Sapphire Sport Becomes 359 Capital
    10/11/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  •  and
  • announced
  • today
  •  the
  • june
  • company
  • Tech
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Travel

South Korea’s Leading Hair Loss Treatment Company, AESMED Co., Ltd., to Participate in Cosmoprof Asia Hong Kong 2025

PRNW Agency
Last updated: 28/10/2025 5:32 PM
PRNW Agency
Share
4 Min Read
South Korea’s Leading Hair Loss Treatment Company, AESMED Co., Ltd., to Participate in Cosmoprof Asia Hong Kong 2025
SHARE
South Korea’s Leading Hair Loss Treatment Company, AESMED Co., Ltd., to Participate in Cosmoprof Asia Hong Kong 2025

AESMED to Focus on Promoting the 1111 Hair Care Day Campaign

- Advertisement -

SEOUL, South Korea, Oct. 28, 2025 /PRNewswire/ — AESMED Co., Ltd., a leading hair loss treatment company in South Korea, announced its participation in Cosmoprof Asia Hong Kong 2025, the largest B2B international beauty trade fair in Asia, to be held from November 12–14, 2025, at the Hong Kong Convention & Exhibition Centre. Cosmoprof Asia brings together global beauty leaders to present the latest technologies, product innovations, and solutions, serving as a key platform shaping the beauty industry worldwide.

- Advertisement -

At Cosmoprof Asia Hong Kong 2025, AESMED will highlight its non-profit campaign, 1111 Hair Care Day. The campaign was launched in 2020 to improve awareness of hair loss treatment and provide opportunities and confidence to those experiencing hair loss. Inspired by the transformation from “1011,” representing missing hair strands, to “1111,” symbolizing full hair, the campaign designates October 11 to November 11 each year as the “Hair Care Season,” with November 11 declared as “Hair Care Day.” Beginning during the COVID-19 pandemic, the campaign marks its sixth year in 2025. It has gained participation of leading Korean hair loss clinics and overseas partners in China, Japan, Malaysia, Turkey, and Azerbaijan.

- Advertisement -

AESMED has been a pioneer in the Korean hair loss treatment market for more than 20 years. In 2012, AESMED developed the alopecia cytokines therapy, which analyzes the mechanisms of cytokines that induce hair loss (produced by DHT) as well as cytokines that suppress them and promote hair growth. This innovative therapy has become an essential program at major hair loss clinics in South Korea and has been well-received by clinics in many countries, regardless of ethnicity or religion.

- Advertisement -

Globally, the population experiencing hair loss is increasing rapidly, and medical technologies for hair loss treatment are advancing. However, social awareness remains limited. A recent study published in July 2025 by the Biomedical Research Institute of Inha University Hospital(Director Gwang-Seong Choi) reported that among female hair loss patients, depression, anxiety, and quality-of-life scores worsened in proportion to the severity of hair loss. Patients struggle with changes in appearance, emotional distress, social withdrawal, and rising medical expenses.

- Advertisement -

AESMED’s 1111 Hair Care Day campaign stresses that hair loss is a serious social issue affecting well-being. By dedicating November 11 each year, the campaign seeks to raise public awareness and foster empathy toward hair loss as a general health concern.

- Advertisement -

Furthermore, AESMED intends to leverage the 2026 World Congress for Hair Research, held in Seoul, to expand the campaign’s global reach.

- Advertisement -

CEO Jeongwoo Yi of AESMED stated, “Any commemorative day must not be driven by commercial interests but should carry public value. It should serve as the thread and needle that unites scattered efforts. I hope to one day witness a global web seminar on hair loss, with participation from the entire industry and academia, held on November 11.”

- Advertisement -

For more information, please visit www.aesmed.co.kr. 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2805639/251023.jpg 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/south-koreas-leading-hair-loss-treatment-company-aesmed-co-ltd-to-participate-in-cosmoprof-asia-hong-kong-2025-302596071.html

- Advertisement -
Open Compute Project Expands Open Chiplet Economy Ecosystem
Agora Wins Best Communications API at 2025 API World Conference
Chantecaille Expands to India: A New Era of Luxury Skincare and Botanical Beauty
ZETADISPLAY AB (publ) INTERIM REPORT 1 APRIL 30 JUNE 2025 (Q2)
Rwanda Celebrates Completion of Smart Education Project and DigiTruck Launch
TAGGED:2025aesmedannouncedasiabeautycampaigncareco.companycosmoprofdayfairfocushairheldhonginternationalkongkoreakoreaslargestleadinglossltdnewsnovemberoctparticipateparticipationpromotingseoulsouthtradetreatmentyear
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

NABR Comment on IUCN Determination
News

NABR Comment on IUCN Determination

14/10/2025

As Agentic AI Gains Traction, 86% of Enterprises Anticipate Heightened Risks, Yet Only 2% of Companies Meet Responsible AI Gold Standards

14/08/2025
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Health

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

15/06/2025
Aukera Celebrates Dhanteras with their Infinity Diamond – Co-Created for prosperity with Dr. Jai Madaan
Travel

Aukera Celebrates Dhanteras with their Infinity Diamond – Co-Created for prosperity with Dr. Jai Madaan

17/10/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?